Y
Yuka Kanno
Researcher at National Institutes of Health
Publications - 98
Citations - 19864
Yuka Kanno is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Cellular differentiation & T cell. The author has an hindex of 56, co-authored 93 publications receiving 17367 citations. Previous affiliations of Yuka Kanno include University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Interleukin-2 Signaling via STAT5 Constrains T Helper 17 Cell Generation
Arian Laurence,Cristina M. Tato,Todd S. Davidson,Yuka Kanno,Zhi Chen,Zhengju Yao,Rebecca Blank,Françoise Meylan,Richard M. Siegel,Lothar Hennighausen,Ethan M. Shevach,John J. O'Shea +11 more
TL;DR: It is demonstrated that in addition to the promotion of activation-induced cell death of lymphocytes and the generation of Treg cells, inhibition of Th17 polarization appears to be an important function of IL-2.
Journal ArticleDOI
Generation of pathogenic T H 17 cells in the absence of TGF-β signalling
Kamran Ghoreschi,Arian Laurence,Xiang-Ping Yang,Cristina M. Tato,Mandy J. McGeachy,Joanne E. Konkel,Haydeé L. Ramos,Lai Wei,Todd S. Davidson,Nicolas Bouladoux,John R. Grainger,Qian Chen,Yuka Kanno,Wendy T. Watford,Hong-Wei Sun,Gérard Eberl,Ethan M. Shevach,Yasmine Belkaid,Daniel J. Cua,Wanjun Chen,John J. O'Shea +20 more
TL;DR: In this article, the authors show that T(H)17 differentiation can occur in the absence of TGF-β signalling, without the need of transforming growth factor (TGF)-β1.
Journal ArticleDOI
Global Mapping of H3K4me3 and H3K27me3 Reveals Specificity and Plasticity in Lineage Fate Determination of Differentiating CD4+ T Cells
Gang Wei,Lai Wei,Jinfang Zhu,Chongzhi Zang,Jane Hu-Li,Zhengju Yao,Kairong Cui,Yuka Kanno,Tae-Young Roh,Wendy T. Watford,Dustin E. Schones,Weiqun Peng,Hong-Wei Sun,William E. Paul,John J. O'Shea,Keji Zhao +15 more
TL;DR: Although modifications of signature-cytokine genes (Ifng, Il4, and Il17) partially conform to the expectation of lineage commitment, genes encoding transcription factors like Tbx21 exhibit a broad spectrum of epigenetic states, consistent with the demonstrated T-bet and interferon-gamma induction in nTreg cells.
Journal ArticleDOI
Impaired T H 17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Joshua D. Milner,Jason M. Brenchley,Jason M. Brenchley,Arian Laurence,Alexandra F. Freeman,Brenna J. Hill,Kevin M. Elias,Kevin M. Elias,Yuka Kanno,Christine Spalding,Houda Elloumi,Michelle L. Paulson,Joie Davis,Amy P. Hsu,Ava I. Asher,John J. O'Shea,Steven M. Holland,William E. Paul,Daniel C. Douek +18 more
TL;DR: Ex vivo T cells from subjects with HIES failed to produce IL-17, but not IL-2, tumour-necrosis factor or interferon-γ, on mitogenic stimulation with staphylococcal enterotoxin B or on antigenic stimulation with Candida albicans or streptokinase, which is consistent with a crucial role for STAT3 signalling in the generation of TH17 cells.
Journal ArticleDOI
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases.
Daniella M. Schwartz,Yuka Kanno,Alejandro V. Villarino,Michael E. Ward,Massimo Gadina,John J. O'Shea +5 more
TL;DR: The biology of JAKs is discussed from a translational perspective, focusing on recent insights from clinical trials, the development of novel agents and the use of jakinibs in a spectrum of immune and inflammatory diseases.